CLINICAL_TRIALS
trial_result
· 2021-02-10
Clinical Trial Update: Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis [Phase 3]
Summary
Phase 3 trial update on nitazoxanide for prevention of secondary spontaneous bacterial peritonitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: UNKNOWN